288 related articles for article (PubMed ID: 24681128)
1. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.
Fontana RJ; Hayashi PH; Gu J; Reddy KR; Barnhart H; Watkins PB; Serrano J; Lee WM; Chalasani N; Stolz A; Davern T; Talwakar JA;
Gastroenterology; 2014 Jul; 147(1):96-108.e4. PubMed ID: 24681128
[TBL] [Abstract][Full Text] [Related]
2. Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
Chalasani N; Bonkovsky HL; Fontana R; Lee W; Stolz A; Talwalkar J; Reddy KR; Watkins PB; Navarro V; Barnhart H; Gu J; Serrano J;
Gastroenterology; 2015 Jun; 148(7):1340-52.e7. PubMed ID: 25754159
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.
Molleston JP; Fontana RJ; Lopez MJ; Kleiner DE; Gu J; Chalasani N;
J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):182-9. PubMed ID: 21788760
[TBL] [Abstract][Full Text] [Related]
5. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.
Fontana RJ; Hayashi PH; Barnhart H; Kleiner DE; Reddy KR; Chalasani N; Lee WM; Stolz A; Phillips T; Serrano J; Watkins PB;
Am J Gastroenterol; 2015 Oct; 110(10):1450-9. PubMed ID: 26346867
[TBL] [Abstract][Full Text] [Related]
6. Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance.
Russo MW; Steuerwald N; Norton HJ; Anderson WE; Foureau D; Chalasani N; Fontana RJ; Watkins PB; Serrano J; Bonkovsky HL
Liver Int; 2017 May; 37(5):757-764. PubMed ID: 27860186
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury.
Ghabril M; Gu J; Yoder L; Corbito L; Ringel A; Beyer CD; Vuppalanchi R; Barnhart H; Hayashi PH; Chalasani N
Gastroenterology; 2019 Nov; 157(5):1245-1252.e3. PubMed ID: 31302142
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobials and Antiepileptics Are the Leading Causes of Idiosyncratic Drug-induced Liver Injury in American Children.
DiPaola F; Molleston JP; Gu J; Cirulli ET; Chalasani N; Barnhart H; Kleiner DE; Hoofnagle JH; Fontana RJ;
J Pediatr Gastroenterol Nutr; 2019 Aug; 69(2):152-159. PubMed ID: 31169665
[TBL] [Abstract][Full Text] [Related]
9. Heavy Consumption of Alcohol is Not Associated With Worse Outcomes in Patients With Idiosyncratic Drug-induced Liver Injury Compared to Non-Drinkers.
Dakhoul L; Ghabril M; Gu J; Navarro V; Chalasani N; Serrano J;
Clin Gastroenterol Hepatol; 2018 May; 16(5):722-729.e2. PubMed ID: 29306044
[TBL] [Abstract][Full Text] [Related]
10. Death and liver transplantation within 2 years of onset of drug-induced liver injury.
Hayashi PH; Rockey DC; Fontana RJ; Tillmann HL; Kaplowitz N; Barnhart HX; Gu J; Chalasani NP; Reddy KR; Sherker AH; Hoofnagle JH;
Hepatology; 2017 Oct; 66(4):1275-1285. PubMed ID: 28543844
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced liver injury.
Leise MD; Poterucha JJ; Talwalkar JA
Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
[TBL] [Abstract][Full Text] [Related]
12. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
[TBL] [Abstract][Full Text] [Related]
13. Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.
Yeboah-Korang A; Memon A; Patel N; Portocarrero-Castillo A; Osman A; Kleesattel D; Lopez C; Louissaint J; Sherman K; Fontana R
Dig Dis Sci; 2022 Nov; 67(11):5262-5271. PubMed ID: 35122190
[TBL] [Abstract][Full Text] [Related]
14. Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury.
Ghabril M; Gu J; Yoder L; Corbito L; Dakhoul L; Ringel A; Beyer CD; Vuppalanchi R; Barnhart H; Hayashi PH; Chalasani N
Clin Transl Gastroenterol; 2020 Apr; 11(4):e00141. PubMed ID: 32251016
[TBL] [Abstract][Full Text] [Related]
15. Amoxicillin-Clavulanate-Induced Liver Injury.
deLemos AS; Ghabril M; Rockey DC; Gu J; Barnhart HX; Fontana RJ; Kleiner DE; Bonkovsky HL;
Dig Dis Sci; 2016 Aug; 61(8):2406-2416. PubMed ID: 27003146
[TBL] [Abstract][Full Text] [Related]
16. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
[TBL] [Abstract][Full Text] [Related]
17. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
Shen T; Liu Y; Shang J; Xie Q; Li J; Yan M; Xu J; Niu J; Liu J; Watkins PB; Aithal GP; Andrade RJ; Dou X; Yao L; Lv F; Wang Q; Li Y; Zhou X; Zhang Y; Zong P; Wan B; Zou Z; Yang D; Nie Y; Li D; Wang Y; Han X; Zhuang H; Mao Y; Chen C
Gastroenterology; 2019 Jun; 156(8):2230-2241.e11. PubMed ID: 30742832
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced liver injury caused by intravenously administered medications: the Drug-induced Liver Injury Network experience.
Ghabril M; Fontana R; Rockey D; Jiezhun G; Chalasani N
J Clin Gastroenterol; 2013 Jul; 47(6):553-8. PubMed ID: 23388845
[TBL] [Abstract][Full Text] [Related]
19. Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury.
Medina-Caliz I; Robles-Diaz M; Garcia-Muñoz B; Stephens C; Ortega-Alonso A; Garcia-Cortes M; González-Jimenez A; Sanabria-Cabrera JA; Moreno I; Fernandez MC; Romero-Gomez M; Navarro JM; Barriocanal AM; Montane E; Hallal H; Blanco S; Soriano G; Roman EM; Gómez-Dominguez E; Castiella A; Zapata EM; Jimenez-Perez M; Moreno JM; Aldea-Perona A; Hernández-Guerra M; Prieto M; Zoubek ME; Kaplowitz N; Lucena MI; Andrade RJ;
J Hepatol; 2016 Sep; 65(3):532-42. PubMed ID: 27184533
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study.
Chalasani N; Bonkovsky HL; Stine JG; Gu J; Barnhart H; Jacobsen E; Björnsson E; Fontana RJ; Kleiner DE; Hoofnagle JH;
J Hepatol; 2022 Apr; 76(4):832-840. PubMed ID: 34953957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
